467776310	467776310	CD	B-NP	O
|	|	NN	I-NP	O
TMH	TMH	NN	I-NP	O
|	|	NN	I-NP	O
75431077	75431077	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7435567	7435567	CD	B-NP	O
|	|	CC	I-NP	O
11/29/2006	11/29/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Non	Non	NNP	I-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/21/2006	4/21/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/26/2006	7/26/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
LANTON	LANTON	NNP	B-NP	O
,	,	,	O	O
ORVAL	ORVAL	NNP	B-NP	O
939-57-15-6	939-57-15-6	CD	I-NP	O
Bufft	Bufft	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
6/14/06	6/14/06	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BECKETT	BECKETT	NNP	B-NP	O
,	,	,	O	O
COLIN	COLIN	NNP	B-NP	O
WALLY	WALLY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACEBUTOLOL	ACEBUTOLOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
400	400	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
4/30	4/30	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
VITAMIN	VITAMIN	NNP	I-NP	I-protein
C	C	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ASCORBIC	ASCORBIC	NNP	I-NP	I-protein
ACID	ACID	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
CALCIUM	CALCIUM	NNP	I-NP	I-protein
CARBONATE	CARBONATE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
ELEMENTAL	ELEMENTAL	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	B-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
4	4	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Starting	Start	VBG	B-VP	I-protein
Today	Today	NN	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
5/30	5/30	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

DIGOXIN	DIGOXIN	NN	B-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
LOVENOX	LOVENOX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
ENOXAPARIN	ENOXAPARIN	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
SC	SC	NN	I-NP	O
BEDTIME	BEDTIME	NN	I-NP	O
TARCEVA	TARCEVA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ERLOTINIB	ERLOTINIB	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HT	HT	NN	I-NP	O
:	:	:	O	O
61.0	61.0	CD	B-NP	O
in	in	IN	B-ADVP	O
.	.	.	O	O

154.9	154.9	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

WT	WT	NN	B-NP	O
:	:	:	O	O
129.5	129.5	CD	B-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

BSA	BSA	NN	B-NP	O
:	:	:	O	O
2.20	2.20	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Primary	Primary	JJ	I-NP	O
DX	DX	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
Day	Day	NN	I-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
3/4/06	3/4/06	CD	B-NP	O
Previous	Previous	JJ	I-NP	O
-	-	HYPH	I-NP	O
Weight	Weight	NN	I-NP	O
:	:	:	O	O
136	136	CD	B-NP	O
kg	kg	NN	I-NP	O
BSA	BSA	NN	I-NP	O
:	:	:	O	O
2.24	2.24	CD	B-NP	O
Admit	Admit	NN	I-NP	O
-	-	HYPH	B-NP	O
Weight	Weight	NN	I-NP	O
:	:	:	O	O
129.5	129.5	CD	B-NP	O
kg	kg	NN	I-NP	O
BSA	BSA	NN	I-NP	O
:	:	:	O	O
2.20	2.20	CD	B-NP	O
FOLIC	FOLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/16	10/16	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
DILAUDID	DILAUDID	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
HYDROMORPHONE	HYDROMORPHONE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/14/06	6/14/06	CD	B-NP	O
by	by	IN	B-PP	O
BORSH	BORSH	NN	B-NP	B-protein
,	,	,	O	O
WADE	WADE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILAUDID	DILAUDID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
327476979	327476979	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
PERCOCET	PERCOCET	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/14/06	6/14/06	CD	B-NP	O
by	by	IN	B-PP	O
WILBANKS	WILBANKS	NNP	B-NP	O
,	,	,	O	O
JASPER	JASPER	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
HYDROMORPHONE	HYDROMORPHONE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIDODERM	LIDODERM	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
LIDOCAINE	LIDOCAINE	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
EA	EA	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
12h	12h	CD	B-NP	O
on/12h	on/12h	NN	I-NP	O
off	off	RB	B-ADVP	O
,	,	,	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
L	L	NN	B-NP	B-DNA
breast	breast	NN	I-NP	I-DNA
PRAVACHOL	PRAVACHOL	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
PRAVASTATIN	PRAVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
BEDTIME	BEDTIME	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

VITAMIN	VITAMIN	NN	B-NP	O
B6	B6	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PYRIDOXINE	PYRIDOXINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ULTRAM	ULTRAM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/14/06	6/14/06	CD	B-NP	O
by	by	IN	B-PP	O
INTERIANO	INTERIANO	NNP	B-NP	O
,	,	,	O	O
FLOYD	FLOYD	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DILAUDID	DILAUDID	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
327476979	327476979	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
TRAMADOL	TRAMADOL	NN	B-NP	O
HCL	HCL	NN	I-NP	O
&	&	CC	I-NP	O
HYDROMORPHONE	HYDROMORPHONE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/26/06	1/26/06	CD	B-NP	O
by	by	IN	B-PP	O
NOGALES	NOGALES	NNP	B-NP	O
,	,	,	O	O
ARNOLD	ARNOLD	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ULTRAM	ULTRAM	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
567958124	567958124	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
PERCOCET	PERCOCET	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
MD	MD	NN	B-NP	O
aware	aware	JJ	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/26/06	1/26/06	CD	B-NP	O
by	by	IN	B-PP	O
BECKLIN	BECKLIN	NNP	B-NP	O
,	,	,	O	O
JOAN	JOAN	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
.	.	.	O	O

POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
MORPHINE	MORPHINE	NNP	B-NP	O
&	&	CC	I-NP	O
TRAMADOL	TRAMADOL	NNP	I-NP	O
HCL	HCL	NN	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
dc	dc	VB	I-VP	O
morphine	morphine	NN	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lagnese	Lagnese	NNP	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Olufson	Olufson	NNP	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-PP	O
schedule	schedule	NN	B-NP	O
964-065-0067	964-065-0067	CD	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Izzard	Izzard	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
5/18/07	5/18/07	CD	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
PERCOCET	PERCOCET	NN	B-NP	O
,	,	,	O	O
DICLOXACILLIN	DICLOXACILLIN	NNP	B-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
,	,	,	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Chest	Chest	NNP	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Non	Non	NNP	I-NP	O
cardiac	cardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
MVA	MVA	NNP	B-NP	O
8/06	8/06	CD	I-NP	O
s/p	s/p	NN	I-NP	O
B	B	NN	I-NP	O
TKA	TKA	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
svt	svt	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
supraventricular	supraventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
thrombophlebitis	thrombophlebitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
superficial	superficial	JJ	I-NP	O
thrombophlebitis	thrombophlebitis	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
recurrent	recurrent	JJ	I-NP	O
bilat	bilat	NN	I-NP	O
LE	LE	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pernicious	pernicious	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
pernicious	pernicious	JJ	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
afib	afib	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
dvt	dvt	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
deep	deep	JJ	I-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
multiple	multiple	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
cellulitis	cellulitis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
cellulitis	cellulitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
*****	*****	SYM	B-NP	O
81	81	CD	B-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
Afib	Afib	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
fondaparinux	fondaparinux	NN	B-NP	O
no	no	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
epistaxis	epistaxis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
NSC	NSC	NNP	B-NP	O
lung	lung	NN	I-NP	O
ca	ca	NN	I-NP	O
,	,	,	O	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
constant	constant	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

pleuritic	pleuritic	JJ	B-ADJP	O
,	,	,	I-ADJP	O
not	not	RB	I-ADJP	O
exertional	exertional	JJ	I-ADJP	O
,	,	,	O	O
related	relate	VBN	B-VP	O
mostly	mostly	RB	B-ADVP	O
to	to	TO	B-PP	O
arm	arm	NN	B-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

Concern	Concern	NN	B-NP	O
for	for	IN	B-PP	O
bone	bone	NN	B-NP	O
met	meet	VBD	B-VP	O
vs.subsegmental	vs.subsegmental	JJ	B-NP	O
PE	PE	NN	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
fondapurinox	fondapurinox	NN	B-NP	O
as	as	IN	B-PP	O
oupt	oupt	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
lung	lung	NN	B-NP	O
ca	ca	NN	I-NP	O
and	and	CC	I-NP	O
afib	afib	NN	I-NP	O
with	with	IN	B-PP	O
intolerance	intolerance	NN	B-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
work	work	NN	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
question	question	NN	B-NP	O
of	of	IN	B-PP	O
breast	breast	NN	B-NP	O
nodule	nodule	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
identifies	identify	VBZ	B-VP	O
one	one	CD	B-NP	O
particular	particular	JJ	I-NP	O
area	area	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
feels	feel	VBZ	B-VP	O
is	be	VBZ	B-VP	O
the	the	DT	B-NP	O
primary	primary	JJ	I-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

*****	*****	SYM	O	O
In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
PE	PE	NN	B-NP	O
CT	CT	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
ekg	ekg	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

ASA	ASA	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
change	change	NN	I-NP	O
with	with	IN	B-PP	O
NGL	NGL	NN	B-NP	B-protein
.	.	.	O	O

*****	*****	SYM	O	O
Patient	Patient	NN	B-NP	O
status	status	NN	I-NP	O
:	:	:	O	O
AF	AF	NN	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	O
125/51	125/51	CD	I-NP	O
P60	P60	NN	I-NP	O
O2	O2	NN	I-NP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
RR18	RR18	NN	I-NP	O
AAO	AAO	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
,	,	,	O	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
resting	rest	VBG	I-NP	O
and	and	CC	I-VP	O
breathing	breathe	VBG	I-VP	O
comfortably	comfortably	RB	B-NP	O
irr	irr	JJ	I-NP	O
irr	irr	IN	I-NP	O
1-2/6	1-2/6	CD	I-NP	O
SEM	SEM	NN	I-NP	O
crackles	crackle	NNS	I-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
+	+	SYM	B-NP	O
palpable	palpable	JJ	I-NP	O
L	L	NN	I-NP	O
breast	breast	NN	I-NP	O
mass	mass	NN	I-NP	O
at	at	IN	B-PP	O
approx	approx	NN	B-NP	O
12	12	CD	I-NP	O
oclock	oclock	VBP	B-VP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
inches	inch	NNS	I-NP	O
above	above	IN	B-PP	O
nipple	nipple	NN	B-NP	O
,	,	,	O	O
diffusely	diffusely	RB	B-NP	O
nodular	nodular	JJ	I-NP	O
breasts	breast	NNS	I-NP	O
abd	abd	VBP	B-VP	O
soft	soft	JJ	B-NP	O
nt	nt	NN	I-NP	O
Ext	Ext	NN	I-NP	O
1	1	CD	I-NP	O
+	+	SYM	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
calf	calf	NN	I-NP	O
tenderness	tenderness	NN	I-NP	O
*****	*****	SYM	B-VP	O
Significant	Significant	JJ	B-NP	O
studies	study	NNS	I-NP	O
:	:	:	O	O
CT-PE	CT-PE	NN	B-NP	O
:	:	:	O	O
IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
embolism	embolism	NN	I-NP	O
or	or	CC	O	O
deep	deep	JJ	B-NP	O
venous	venous	JJ	I-NP	O
thrombosis	thrombosis	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Post	Post	RBS	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
resection	resection	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Interval	Interval	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
lobe	lobe	NN	I-NP	O
nodule	nodule	NN	I-NP	O
without	without	IN	B-PP	O
new	new	JJ	B-NP	O
nodules	nodule	NNS	I-NP	O
.	.	.	O	O

per	per	IN	B-PP	O
discussion	discussion	NN	B-NP	O
with	with	IN	B-PP	O
radiology	radiology	NN	B-NP	O
possible	possible	JJ	I-NP	O
chronic	chronic	JJ	I-NP	O
subsegmental	subsegmental	JJ	I-NP	O
PE	PE	NN	I-NP	O
CXR-no	CXR-no	JJ	I-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
+	+	SYM	B-VP	O
lupus	lupus	NN	B-NP	O
anticoag	anticoag	NN	I-NP	O
*****	*****	SYM	O	O
Problem	Problem	NNP	B-NP	O
List/Hospital	List/Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
Chest	Ch	JJS	I-NP	O
pain-No	pain-No	NN	I-NP	B-protein
met	meet	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
CXR	CXR	NN	B-NP	B-protein
or	or	CC	I-NP	O
CT.	CT.	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
large	large	JJ	I-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
evidence	evidence	NN	B-NP	O
for	for	IN	B-PP	O
pulm	pulm	NN	B-NP	O
HTN	HTN	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
PE	PE	NN	I-NP	O
and	and	CC	O	O
outpt	outpt	JJ	B-NP	O
treatment	treatment	NN	I-NP	O
with	with	IN	B-PP	O
fondapurinox	fondapurinox	NN	B-NP	O
will	will	MD	B-VP	O
transition	transition	VB	I-VP	O
to	to	TO	B-PP	O
lovenox	lovenox	NN	B-NP	O
while	while	IN	B-SBAR	O
inpatient	inpatient	NN	B-NP	O
for	for	IN	B-PP	O
maintenance	maintenance	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
intolerance	intolerance	NN	I-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
with	with	IN	B-PP	O
epistaxis	epistaxis	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
process	process	NN	I-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
no	no	DT	B-NP	O
hypoxia	hypoxia	NN	I-NP	O
,	,	,	O	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
may	may	MD	B-VP	O
be	be	VB	I-VP	O
related	related	JJ	B-ADJP	O
to	to	TO	B-PP	O
painful	painful	JJ	B-NP	O
breast	breast	NN	I-NP	O
lump	lump	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
will	will	MD	B-VP	O
have	have	VB	I-VP	O
mammogram	mammogram	NN	B-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
,	,	,	O	O
continue	continue	VBP	B-VP	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
Lidoderm	Lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
ultram	ultram	NN	B-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
dilaudid	dilaudid	VBD	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Lung	Lung	NN	B-NP	B-protein
CA	CA	NN	I-NP	I-protein
-	-	HYPH	O	O
Continuing	Continue	VBG	B-VP	O
tarceva	tarceva	NN	B-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
oncologist	oncologist	NN	I-NP	O
Dr	Dr	NNP	I-NP	O
Goetzke	Goetzke	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
imaging	imaging	NN	B-NP	O
but	but	CC	O	O
would	would	MD	B-VP	O
consider	consider	VB	I-VP	O
bone	bone	NN	B-NP	O
scan	scan	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
oupatient	oupatient	NN	I-NP	O
if	if	IN	B-SBAR	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
A	A	DT	B-NP	O
fib	fib	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
Lowered	Lowered	JJ	I-NP	O
acebutolol	acebutolol	NN	I-NP	O
dose	dose	NN	I-NP	O
from	from	IN	B-PP	O
400mg	400mg	CD	B-NP	O
BID	BID	NNP	I-NP	O
to	to	TO	B-VP	O
400mg	400mg	VB	I-VP	O
daily	daily	RB	B-ADVP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
intermittent	intermittent	JJ	B-NP	B-protein
bradycardia	bradycardia	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
asymptomatic	asymptomatic	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
fondaparinux	fondaparinux	NN	I-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
on	on	IN	B-PP	O
lovenox	lovenox	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

*	*	SYM	O	O
CHF-gently	CHF-gently	RB	B-VP	O
diuresing	diurese	VBG	I-VP	O
,	,	,	O	O
restarting	restart	VBG	B-VP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
lasix	lasix	NN	B-NP	O
on	on	IN	B-PP	O
6/23	6/23	CD	B-NP	O
at	at	IN	B-PP	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
crackles	crackle	NNS	B-NP	O
at	at	IN	B-PP	O
left	left	JJ	B-NP	O
base	base	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
and	and	CC	O	O
titrate	titrate	VB	B-VP	O
lasix	lasix	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

*	*	SYM	O	O
ID	ID	NN	B-NP	O
-	-	HYPH	I-NP	O
Klebsiella	Klebsiella	NN	I-NP	O
UTI	UTI	NN	I-NP	O
,	,	,	O	O
treating	treat	VBG	B-VP	O
with	with	IN	B-PP	O
Cipro	Cipro	NN	B-NP	B-protein
starting	start	VBG	B-VP	I-protein
6/23	6/23	CD	B-NP	I-protein
with	with	IN	B-PP	O
250mg	250mg	CD	B-NP	O
BID	BID	NN	I-NP	O
*	*	SYM	B-NP	O
Pain	Pain	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
tx	tx	NN	I-NP	O
with	with	IN	B-PP	O
lidoderm	lidoderm	NN	B-NP	O
patch	patch	NN	I-NP	O
,	,	,	O	O
ultram	ultram	NN	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
adding	add	VBG	B-VP	O
low	low	JJ	B-NP	O
dose	dose	NN	I-NP	O
dilaudid	dilaudid	NN	I-NP	O
for	for	IN	B-PP	O
treatment	treatment	NN	B-NP	O
of	of	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
Dispo	Dispo	NN	B-NP	O
to	to	TO	B-PP	O
rehabilitation	rehabilitation	NN	B-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
reconditioning	reconditioning	NN	I-NP	O
and	and	CC	I-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
functional	functional	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
CODE	CODE	NN	B-NP	O
:	:	SYM	O	O
FULL	FULL	NN	B-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Ms	Ms	NNP	B-NP	O
Cheramie	Cheramie	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
pleasure	pleasure	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
involved	involve	VBN	I-VP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Sauro	Sauro	NNP	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
oncologist	oncologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Willard	Willard	NNP	I-NP	O
Camps	Camps	NNP	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
also	also	RB	B-ADVP	O
keep	keep	VB	B-VP	O
your	your	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
mammogram	mammogram	NN	B-NP	O
as	as	IN	B-SBAR	O
scheduled	schedule	VBN	B-VP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
at	at	IN	B-PP	O
PNH	PNH	NNP	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
yoru	yoru	NN	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Bennie	Bennie	NNP	I-NP	O
Tomaselli	Tomaselli	NNP	I-NP	O
for	for	IN	B-PP	O
continued	continued	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
conditions	condition	NNS	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
continue	continue	VBP	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
specialists	specialist	NNS	I-NP	O
to	to	TO	B-VP	O
try	try	VB	I-VP	O
to	to	TO	I-VP	O
regain	regain	VB	I-VP	O
strength	strength	NN	B-NP	O
and	and	CC	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
Factor	Factor	NNP	I-NP	O
Xa	Xa	NNP	I-NP	O
level	level	NN	I-NP	O
to	to	TO	B-VP	O
insure	insure	VB	I-VP	O
Lovenox	Lovenox	NN	B-NP	O
dosing	dosing	NN	I-NP	O
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
on	on	IN	B-PP	O
mammogram	mammogram	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
June	June	NNP	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
intermittently	intermittently	RB	B-ADVP	O
to	to	TO	B-VP	O
insure	insure	VB	I-VP	O
adequate	adequate	JJ	B-NP	O
rate	rate	NN	I-NP	O
control	control	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
Acebutolol	Acebutolol	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Continue	Continue	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
at	at	IN	B-PP	O
40mg	40mg	CD	B-NP	O
daily	daily	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
admit	admit	NN	I-NP	O
dose	dose	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
40mg	40mg	JJ	B-ADJP	O
alternating	alternate	VBG	B-VP	O
with	with	IN	B-PP	O
60mg	60mg	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
monitor	monitor	NN	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Complete	Complete	JJ	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
Cipro	Cipro	NNP	B-NP	O
250mg	250mg	CD	I-NP	O
BID	BID	NNP	I-NP	O
x	x	CC	O	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	B-NP	O
doses	dose	NNS	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
for	for	IN	B-PP	O
Klebsiella	Klebsiella	NNP	B-NP	O
UTI	UTI	NNP	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
oncologist	oncologist	NN	B-NP	O
,	,	,	O	O
PCP	PCP	NN	B-NP	B-DNA
and	and	CC	B-PP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
as	as	IN	B-PP	O
above	above	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
WALLINGER	WALLINGER	NNP	B-NP	O
,	,	,	O	O
COLIN	COLIN	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NQ30	NQ30	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6/14/06	6/14/06	CD	I-NP	O
@	@	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
29	29	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

